Julie O'Neill, EVP Global Operations at ALEXION PHARMACEUTICALS INC (ALXN), sold 2,119 shares at $117.26 ($248K) on 2018-02-05, disclosed to the SEC on 2018-02-07.
Seasonal sale ($248k) by EVP Global Operations — this insider has traded ALXN in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| ALXN | SELL | 2018-02-08 | $557K | — | Filing → |
| ALXN | SELL | 2017-09-05 | $636K | — | Filing → |
| ALXN | SELL | 2017-08-30 | $1.6M | — | Filing → |